Hims and Hers just shut down its dermatology business after stock slump on FDA's weight-loss drug decision
Briefly

Hims and Hers is discontinuing Apostrophe, its dermatology business acquired in 2021 for $190 million, to streamline its telehealth services. Effective March 7, all subscriptions will be canceled, and customers will lose access to their accounts after 30 days. The company aims to enhance its skincare services by consolidating operations under its existing dermatology offerings. Despite the closure, which Hims and Hers states is not directly linked to challenges in its weight-loss business or stock performance, it reflects a strategic pivot to create a more cohesive customer experience.
Hims and Hers announced the shutdown of Apostrophe, its skincare service acquired for $190 million, aiming to streamline its dermatology offerings and enhance customer care.
Apostrophe's subscriptions will be canceled as of March 7, with customers losing access to services and encouraged to seek skincare treatment through Hims and Hers.
Read at Business Insider
[
|
]